LGND - Ligand Pharmaceuticals beats on revenue February, 06 2020 04:06 PM Ligand Pharmaceuticals Incorporated Ligand Pharmaceuticals (NASDAQ:LGND): Q4 Non-GAAP EPS of $0.71; GAAP EPS of -$0.43.More news on: Ligand Pharmaceuticals Incorporated, Earnings news and commentary, Healthcare stocks news, Read more ...